Eligible Was Not Sold

Interest disclosure: Tessera PE issues T-SpaceX, a tokenized loan participation right providing economic exposure linked to SpaceX. Following the SpaceX listing, the investment underlying T-SpaceX is being divested. Redemption opens only once a Redemption Start Date is announced, and as of 20 September 2026 none has been. Tessera's founder, and entities he controls, hold related exposure. Read what follows with that in mind.

On 3 August, a piece under this masthead set out three claims about the 6 August SpaceX lock-up release, each falsifiable within the week. That position is uncommon enough to deserve a proper accounting rather than a quiet move to the next topic. Figures below run through the 7 August close.

What the 3 August Piece Said

The first claim was that the conditional early-release tranche of 455.8 million shares would stay locked. The agreement gated it on the stock closing at least 30% above the $135 offer price, roughly $175.50, on five of the ten sessions running into the first earnings release; the stock spent that window between about $107 and $117.

The second was that eligibility and selling are different events. A lock-up expiry converts a legal restriction into a decision, and the decision still has to be made.

The third, and least conventional, was that float mechanics run in both directions. Nasdaq-100 weights are set on free float rather than market capitalization, so as the float expands, the passive holding requirement rises mechanically. The event that adds supply also adds demand.

What Happened

The 4 August earnings print was strong on the top line and unpopular at the bottom of the cash flow statement: revenue of $7.81 billion, up 92% year on year against roughly $6.93 billion expected; a net loss narrowed to $541 million; adjusted EBITDA near $3.5 billion; and capital expenditure of $18.37 billion against a $13.22 billion consensus. The stock fell 13.6% on 5 August to close at $108.27, an all-time low, on 201.2 million shares.

The conditional tranche failed its gate, and it was never close. That left the 6 August release at 911.5 million shares, roughly a third smaller than the maximum the schedule permitted.

On 6 August the shares became eligible and the float moved from about 4.9% of shares outstanding to about 11.8%, more than doubling in a session. The stock closed up 6.1%. On 7 August it closed at $133.11, up 15.83%, on 236.7 million shares against a three-month average near 124.0 million.

Two of the three claims held. The third was never tested, and exactness about that matters more than banking it.

What Was Tested and What Was Not

The price gate resolved; that one is arithmetic, and it is settled.

The eligibility claim resolved. Roughly 911.5 million shares became sellable and the market did not clear at a discount, which is the only evidence that claim ever required.

The float-weighting argument could not resolve, because index weights are revised on a review schedule rather than on the afternoon a lock-up opens. Whatever moved the stock on 6 and 7 August, it was not trackers mechanically buying an expanded free float; that adjustment sits ahead, not behind. Nothing this week contradicted the argument, and nothing this week demonstrated it either. Treating a favorable outcome as confirmation of an untested mechanism is precisely the error the 3 August piece was written to complain about.

Why the Win Stays Unclaimed

The clean-unlock reading, in which supply arrived, nobody sold, and the overhang is now behind the stock, is being written up as a natural experiment. It was not one. Several other things landed inside the same 48 hours. Short positioning had reportedly built into the event, and a rally on that setup forces covering that has nothing to do with anyone's view of the company. Analyst actions were reported the same day, including an Argus upgrade to Buy at a $160 target, a Bernstein target increase from $239 to $248, and a Citi Buy reiteration at $200. SpaceX and Tesla confirmed Terafab, a $16.8 billion first-phase semiconductor campus in Grimes County, Texas, on 6 August. And reporting circulated the same week that a large pending acquisition, of the AI coding company Cursor at a figure reported near $60 billion, could close shortly.

Separating how much of a 15.83% session belongs to the lock-up and how much belongs to the rest cannot be done from the outside, and anyone claiming otherwise is guessing. The defensible statement is narrower and duller: a self-dampening price gate was sitting in the prospectus, it was not priced, and it did what the document said it would do.

One further piece of arithmetic is worth keeping in view. At $133.11 the stock remains below the $135 at which it was sold to the public in June. Two months, one earnings report, and the largest single unlock in the schedule later, the public entry price has not been recovered. None of that predicts where the stock goes next. It is the plainest available illustration of a point argued in this space since before the listing: an IPO is an exit before it is an entry, and the two sides of that transaction do not experience the same event.

Still Ahead, Still Unclear

The 6 August release was the first tranche of a staggered schedule rather than the end of one. Further releases run through the fall, with a substantial tranche tied to the third-quarter report and the balance at the 180-day mark in December.

Two cautions on the detail. Trade coverage currently disagrees on the date and size of the next tranche, with reports placing it variously in mid-August and in late August, and reported float figures do not reconcile cleanly across sources. Where the schedule matters to a decision, the filing is the document to read rather than the write-up.

The largest block sits on almost no calendars at all. Musk and a group of insiders sit outside the staged schedule entirely, on a separate 366-day lock-up running to June 2027, with no early-release provision.

The Part That Transfers

Anthropic filed confidentially on 1 June; OpenAI followed with a confidential filing reported shortly afterwards. Databricks has stayed out. Each will negotiate a lock-up, and the SpaceX structure is now the reference case for how a conditional release behaves under stress.

The design detail worth carrying out of this week is that the gate withheld supply precisely when supply would have been least welcome. Issuers will want that. Holders will price it. And the reading that the lock-up passed without incident is less useful to either side than the reading that the lock-up was engineered to dampen itself, and did.

Of the three things that moved this stock in August (the print, the guidance, and the calendar), the calendar remains the only one that was knowable in advance. It still is.

*Sources: SpaceX Q2 2026 results (4 August 2026); Nasdaq and Yahoo Finance closing prices, 5–7 August 2026; CNN Business and Motley Fool market coverage, 6–7 August 2026; analyst actions as reported 7 August 2026; SpaceX and Tesla Terafab announcement, 6 August 2026. Figures dated as stated and not updated after the 7 August close. * This is market commentary, not investment advice.

High risk. DYOR. Not financial advice. tessera.pe/terms**